News
11 March, 2026
Garvan’s Moss Vale research hub driving cancer trials across NSW
Groundbreaking cancer research linked to Moss Vale is helping more patients across New South Wales access potentially life-saving treatments through a statewide clinical trials network coordinated by the Garvan Institute of Medical Research.
Groundbreaking cancer research linked to Moss Vale is helping more patients across New South Wales access potentially life-saving treatments through a statewide clinical trials network coordinated by the Garvan Institute of Medical Research.
The NSW Early Phase Clinical Trials Alliance (NECTA) brings together doctors, researchers, hospitals and clinical trial specialists to expand access to early-stage cancer trials — the critical first step in testing new treatments in people.
Garvan coordinates the alliance and operates a research presence in Moss Vale, where scientists focus on genomic and precision medicine research aimed at improving the detection and treatment of diseases including cancer.
The work carried out at the Southern Highlands facility forms part of Garvan’s broader effort to translate laboratory discoveries into real treatments.
The NSW Government has invested $450,000 this year through the Cancer Institute NSW to support the program for the 2025/26 and 2026/27 financial years, bringing total state investment in the network to $975,000.
Garvan’s presence in Moss Vale has also featured prominently in debate about whether Repoly should be permitted to operate a plastics recycling facility in the town.
When assessing the proposal, the NSW Independent Planning Commission noted the proximity of Garvan’s research facility, which houses specialised laboratory animals used in medical research.
Concerns were raised about the potential impact of industrial activity, including noise and vibration, on sensitive research work involving laboratory mice.
Local opposition to the Repoly proposal has pointed to the presence of advanced scientific research in Moss Vale as part of the argument that the precinct should support medical research and high-tech industries rather than heavy industry.
Laboratory head at Garvan and Head of Medical Oncology at St Vincent’s Hospital Sydney Professor Anthony Joshua said “Early phase trials can offer another chance for patients who have few options left,” Professor Joshua said.
The alliance aims to make it easier for patients across NSW — including those in regional communities — to access world-class clinical research and new treatments years before they become widely available.
Read More: Moss Vale, Southern Highlands